Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis
- PMID: 17491061
- DOI: 10.1093/annonc/mdm050
Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis
Erratum in
- Ann Oncol. 2008 May;19(5):1027-9
Similar articles
-
Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis.Ann Oncol. 2008 May;19 Suppl 2:ii110-2. doi: 10.1093/annonc/mdn105. Ann Oncol. 2008. PMID: 18456745 No abstract available.
-
Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis.Ann Oncol. 2009 May;20 Suppl 4:156-8. doi: 10.1093/annonc/mdp160. Ann Oncol. 2009. PMID: 19454442 Review. No abstract available.
-
ESMO Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV).Ann Oncol. 2001 Aug;12(8):1059-60. doi: 10.1023/a:1017413507554. Ann Oncol. 2001. PMID: 11583185 No abstract available.
-
ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV).Ann Oncol. 2005;16 Suppl 1:i77-9. doi: 10.1093/annonc/mdi805. Ann Oncol. 2005. PMID: 15888767 No abstract available.
-
Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only).Support Care Cancer. 2011 Mar;19 Suppl 1:S57-62. doi: 10.1007/s00520-010-1039-y. Epub 2010 Dec 5. Support Care Cancer. 2011. PMID: 21132332
Cited by
-
Moxibustion for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis.Evid Based Complement Alternat Med. 2017;2017:9854893. doi: 10.1155/2017/9854893. Epub 2017 Oct 12. Evid Based Complement Alternat Med. 2017. PMID: 29234451 Free PMC article. Review.
-
Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review.Cancer Manag Res. 2009 Dec 16;2:1-12. Cancer Manag Res. 2009. PMID: 21188092 Free PMC article.
-
Latest Update on Prevention of Acute Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer Patients.Curr Oncol Rep. 2019 Aug 15;21(10):89. doi: 10.1007/s11912-019-0840-0. Curr Oncol Rep. 2019. PMID: 31418119 Free PMC article. Review.
-
Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide.Support Care Cancer. 2009 Aug;17(8):1065-70. doi: 10.1007/s00520-008-0545-7. Epub 2008 Dec 6. Support Care Cancer. 2009. PMID: 19066985 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical